Filing Flows › Stemtech (STEK) › Q4 2025
Stemtech (STEK) Q4 2025 earnings results (fourth quarter 2025)
10-K filed May 29, 2026
Stemtech (STEK) reported revenue of $458K for the fourth quarter 2025 (Q4 2025), -65% from a year earlier and -46% from the quarter before. Operating margin was -188.6%, net loss $1.5M (323.6% of revenue).
Stemtech, Q4 2025: revenue $458K (-65% year over year), operating margin -188.6%, net loss $1.5M, operating cash flow $127K. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $458K | -46% | -65% |
| Operating profit | −$864K | — | -2705% |
| Net earnings | −$1.5M | — | — |
| Operating cash flow | $127K | +409% | — |
What changed
Revenue was $458K in Q4 2025, down 65% year over year and down 46% from the previous quarter.
Gross margin was 77.4%, down 2.1 points from Q4 2024. Operating costs exceeded revenue by $864K, an operating margin of -188.6%. Operating expenses grew 20% against a revenue fall of 65%. The quarter ended with a net loss of $1.5M, wider than the previous quarter's $813K loss.
Operating cash flow was $127K. Non-cash charges added back $42K of depreciation and amortization and $111K of share-based compensation. Working capital and other items added $1.5M.
Questions
What was Stemtech's revenue in the fourth quarter 2025?
Stemtech (STEK) reported revenue of $458K for the fourth quarter 2025 (Q4 2025), -65% from a year earlier and -46% from the quarter before.
Was Stemtech profitable in the fourth quarter 2025?
Operating loss was $864K (-188.6% of revenue) and net loss $1.5M.
Source: Stemtech 10-K on SEC EDGAR.